List of works - Marina Caskey

A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract

scientific article

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals

scientific article

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

scientific article

Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

scientific article published on December 2007

Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy

scientific article published on 9 November 2016

Circulating precursors of human CD1c+ and CD141+ dendritic cells

scientific article

Clinical manifestations associated with HTLV type I infection: a cross-sectional study

scientific article published on March 2007

Clinical manifestations in individuals with recent diagnosis of HTLV type I infection

scientific article

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.

scientific article published on 23 April 2018

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

scientific article published in Nature

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

scientific article published on 18 June 2020

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

scientific article published on 23 March 2016

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

scientific article published on 4 January 2012

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

scientific article published on 29 June 2009

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York

scientific article published on 09 August 2021

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

scientific article

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro

scientific article published on 09 September 2020

Enhanced SARS-CoV-2 neutralization by dimeric IgA

scientific article published on 07 December 2020

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

scientific article

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

scientific article

HIV-1 integration landscape during latent and active infection

scientific article

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

scientific article

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

scientific article (publication date: 2011)

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

scientific article published on 14 June 2021

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells

scientific article published on 13 December 2017

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

article

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

scientific article published on 21 November 2016

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine

scientific article

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

scientific article

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

article

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

scientific article published on 7 November 2011

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

scholarly article

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

scientific article published on 08 April 2015

List of works by Marina Caskey

A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy

Circulating precursors of human CD1c+ and CD141+ dendritic cells

Clinical manifestations associated with HTLV type I infection: a cross-sectional study

Clinical manifestations in individuals with recent diagnosis of HTLV type I infection

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

HIV-1 integration landscape during latent and active infection

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.